EP 2054124 A1 20090506 - HAIR TREATMENT PRODUCTS COMPRISING POLYMERS
Title (en)
HAIR TREATMENT PRODUCTS COMPRISING POLYMERS
Title (de)
HAARBEHANDLUNGSMITTEL ENTHALTEND POLYMERE
Title (fr)
AGENT DE TRAITEMENT CAPILLAIRE CONTENANT DES POLYMÈRES
Publication
Application
Priority
- EP 2007059928 W 20070920
- DE 102006050650 A 20061024
Abstract (en)
[origin: DE102006050650A1] Hair treatment agent comprises at least a copolymer (A) of: monomer (I); monomer (II) comprising e.g. (meth)acrylic acid, phosphopropylacrylate and vinylpyrrolidone, and optionally non-ionic monomer; at least a silicone; and at least a caring agent comprising e.g. monomers, oligomers and polymers of amino acids, DNA- or RNA-oligonucleotides, vitamins, alpha -hydroxycarboxylic acid, flavonoid, isoflavonoid enriched plant extract, polyphenol, ubiquinone, silymarin, ectoin, purine, carbohydrates, hydantoin, 2-furanone and taurine. Hair treatment agent comprises at least a copolymer (A) of 0.1-50% of: monomer of formula (H 2C=C(R 1>)-Z-(CH 2) n-N +>(R 2>)(R 3>)-[A-N +>(R 2>)(R 3>)] m-B 1>-N +>(R 4>)(R 5>)(R 6>) (3X ->)) (I); monomer (II) comprising acrylic acid, methacrylic acid, alpha -ethacrylic acid, beta ,beta -dimethyl acrylic acid, vinylacetic acid, allyl acetic acid, ethylidine acetic acid, propylidine acetic acid, crotonic acid, maleic acid, fumaric acid, itaconic acid, citraconic acid, mesaconic acid, N-methacryloylalanine, N-acryloylhydroxyglycine, sulfopropylacrylate, sulfoethylacrylate, sulfoethylmethacrylate, sulfoethylmethacrylate, styrenesulfonic acid, vinylsulfonic acid, vinylphosphonic acid, phosphoethylacrylate, phosphonoethyl acrylate, phosphopropyl acrylate, phosphonopropylacrylate, phosphoethyl methacrylate, phosphonoethyl methacrylate, phosphopropyl methacrylate, phosphonopropyl methacrylate and their alkali metals- and ammonium salts; and optionally non-ionic monomer (III) comprising acrylamide, vinylalcohol, 1-4C-alkylester of (meth)acrylic acid, 1-4C-hydroxyalkylester of (meth)acrylic acid, preferably ethylene glycol- and propylene glycol acrylate and -methacrylate, polyalkoxylated ester of (meth)acrylic acid, preferably polyethylene glycol- and polypropylene glycolester, ester of (meth)acrylic acid with polyethylene glycol- or polypropylene glycol-mono(1-25C)alkyl vinylacetate, vinylpyrrolidone and methylvinylether, where (II) and (III) together amounts to 50-99.9%; at least a silicone; at least a caring agent comprising monomers, oligomers and polymers of amino acids, N-2-24C-acylamino acid and/or their esters or salts; DNA- or RNA-oligonucleotides; vitamins, provitamins and vitamin precursors of the groups A, B, C, E, H and K and their esters; alpha -hydroxycarboxylic acid, alpha -ketocarboxylic acid, beta -hydroxycarboxylic acid and its ester-, lactone- or salt form; flavonoid and flavonoid enriched plant extract; isoflavonoid and isoflavonoid enriched plant extract; polyphenol and polyphenol enriched plant extract; ubiquinone and its derivatives; silymarin; ectoin; purine and its derivatives; carbohydrates comprising monosaccharides, disaccharides and/or oligosaccharides; hydantoin or its derivatives; 2-furanone or its derivatives; taurine (2-aminoethanesulfonic acid); and/or carnitine, carnitine tartrate, carnitine magnesium citrate, acetylcarnitine, 3-O-lauroyl-L-carnitine hydrochloride, 3-O-octanoyl-L-carnitine hydrochloride, 3-O-palmitoyl-L-carnitine hydrochloride, taurine, taurine lysylate, taurine tartrate, taurine ornithate, lysyl taurine and ornithyl taurine, betalain, 1,1-dimethyl-proline, hercynine (Nalpha ,Nalpha ,Nalpha -trimethyl-L-histidinium-betaine), ergothioneine (thionein, 2-mercapto-Nalpha ,Nalpha ,Nalpha -trimethyl-L-histidinium-betaine), choline, choline chloride, choline bitartrate or choline dihydrogen citrate. R 1>H, CH 3 (preferred) or CH 2CH 3; R 2>-R 6>H, CH 3 (preferred), CH 2CH 3, (CH 2) 2CH 3, CH(CH 3) 2, (CH 2) 3CH 3, CH(CH 3)CH 2CH 3, CH 2CH(CH 3) 2, C(CH 3) 2, CH 2-OH, (CH 2) 2-OH, CH(OH)-CH 3, CH(OH)CH 2CH 3, CH 2CH(OH)CH 3, (CH 2) 3OH, CH 2-NH 2, (CH 2) 2-NH 2, CH(NH 2)-CH 3, CH(NH 2)CH 2CH 3, CH 2CH(NH 2)CH 3 or (CH 2) 3NH 2; n : 1-6, preferably 2, 3 (preferred) or 4; m : 0-10, preferably 0 (preferred), 1 or 2; Z : O, -C(O)-O- or -C(O)-NH- (preferred); A : -(CH 2) 2-, -(CH 2) 3-, -(CH 2) 4- (all preferred), -CH 2-, -(CH 2) 5- or -(CH 2) 6-; B 1>2-12C, preferably 3-6C-polymethylene chain (optionally interrupted one or more heteroatoms, preferably -O- or -NH-, and optionally substituted with one or more hydroxy- and/or amino group), preferably -(CH 2) 3-, -(CH 2) 4-, -(CH 2) 5-, -(CH 2) 6-, -CH 2-CH(OH)-CH 2- (preferred) or -CH 2-CH(NH 2)-CH 2-; and X : anion, preferably chloride, bromide, iodide, sulfate or methosulfate. An independent claim is included for a method for the treatment of skin or hair, comprising applying the hair treatment agent on the skin and/or hair, and rinsing out the agent after an impact time of 0-45 minutes.
IPC 8 full level
A61Q 5/12 (2006.01); A61K 8/81 (2006.01); A61K 8/89 (2006.01); A61Q 5/00 (2006.01)
CPC (source: EP US)
A61K 8/84 (2013.01 - EP US); A61K 8/891 (2013.01 - EP US); A61Q 5/00 (2013.01 - EP US); A61Q 5/12 (2013.01 - EP US)
Citation (search report)
See references of WO 2008049701A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
DE 102006050650 A1 20080430; AU 2007308244 A1 20080502; CA 2666914 A1 20080502; EP 2054124 A1 20090506; RU 2009119372 A 20101127; US 2009304620 A1 20091210; WO 2008049701 A1 20080502
DOCDB simple family (application)
DE 102006050650 A 20061024; AU 2007308244 A 20070920; CA 2666914 A 20070920; EP 07820372 A 20070920; EP 2007059928 W 20070920; RU 2009119372 A 20070920; US 44660907 A 20070920